The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHardide Regulatory News (HDD)

Share Price Information for Hardide (HDD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.35
Bid: 7.20
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.30 (4.167%)
Open: 7.35
High: 7.35
Low: 7.35
Prev. Close: 7.35
HDD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restoration of trading

3 Jun 2008 14:00

RNS Number : 8547V
Hardide PLC
03 June 2008
 



Press Release

June 2008

Hardide plc 

("Hardide" or "the Company")

Restoration of trading

Placing

Strategic Review

The Board of Hardide plc (AIM:HDD) announces that the suspension of trading of its Ordinary Shares on the AIM market, that commenced on 1 April 2008, will be lifted with effect from 2 p.m. on 3 June 2008.

The suspension of trading in the Ordinary Shares of the Company was requested by the Board whilst it investigated a corporate governance issue which linked to the financial outlook of the CompanyA review of the financial outlook was necessary because of slower growth in the US business and a sudden and unexpected reduction in demand from one of the Company's major customers in the UK. This was due to a customer inventory issue affecting many suppliers and not related to the Company or its technology. Although the reduction in the UK appears to be temporary and orders are now resuming, it is likely to result in the Company's full year results to 30 September 2008 being markedly short of market expectations and thus a requirement for additional capital for day-to-day operations.

During the period of suspension, the Board has been actively seeking a replacement Chief Executive Officer and is pleased to announce the appointment to that role of Dr. Graham Hine. A separate announcement covers this appointment in more detail.

The Board of Hardide has also reviewed the strategic options open to the Company and has reached agreement with a number of its shareholders to subscribe for 42,500,000 new Ordinary Shares at an issue price of 3 pence per share.  In addition, one other existing shareholder has agreed to provide £225,000 in the form of a loan note with a coupon of 8 per cent. and convertible in to Ordinary Shares at a conversion price of 4.5 pence per share. The gross amount raised will be £1.5 million. The new capital will cover operating losses and the development of applications designed to lead to additional near-term and mid-term sales revenue.

Hugh Smith, an existing shareholder and non-executive director of Hardide is participating in the fundraising, subscribing £49,775.01 for 1,659,167 Ordinary Shares.  Application will be made for the new Ordinary Shares to be admitted to trading on AIM in due course.

The Company also wishes to incentivise existing and prospective new management by having the ability to issue additional options over Ordinary Shares under the Company's EMI scheme and in this regard wishes to issue options to the new Chief Executive, other Directors and employees as follows:

Graham Hine

6,000,000

Robert Goddard

1,000,000

Peter Davenport

1,000,000

Yuri Zhuk

1,000,000

Employees

6,845,000

To the extent that employees agree to receive new options, their existing options will be cancelled. It is proposed that each of these grants will have an exercise price of 3 pence per share, which is the Placing Price, and which will vest in three equal tranches over 3 years (for Directors and employees in employment prior to July 2007, vesting to commence from October 2008 and for Directors and employees employed since that date, vesting to commence from October 2009) and will be exercisable after vesting at any time until the tenth anniversary of grant.

 In addition to the placing of the new Ordinary Shares, the terms of the two existing £500,000 shareholder loans due originally to be retired in September 2009 will be extended by one year.  The final exercise date of the associated share option agreements (originally expiring in September 2010) will also be extended by one year and the exercise price reduced to nine pence per share.  The directors, having consulted with Seymour Pierce, the Company's nominated adviser, consider the revised terms to be fair and reasonable insofar as shareholders are concerned.

Hardide will hold an EGM shortly to grant authority to the Board to give effect to the above proposals.

The Company has revised its strategic plan and for the next twelve months will focus on increasing cash generation in the UK operation and commercialising the significant customer interest in the US. Capital and revenue expenditure will be minimised until a firmer upward trend of sales growth is established. Meanwhile, the Company will continue its discussions with potential partners in new international markets.

Robert Goddard, Executive Chairman of Hardide plc, said "The sudden reduction in orders from a major UK customer and slower than expected growth in the US meant that new capital was urgently needed to sustain growth and fund ongoing losses. The Company has re-forecast its sales and its cash requirements under various scenarios and has concluded that the most robust option is to reduce discretionary revenue and capital expenditure over the coming year and concentrate on increasing cash generation in the UK operation.  The new strategic plan has been thoroughly interrogated and the Board believes it to be deliverable.

"The UK operation, Hardide Coatings Limited, was profitable in the first half of the financial year and recent events do not diminish the positive results that the Hardide technology is delivering. The Board remains confident that the technology is proving its value to blue chip customers worldwide through extending the life of their parts and reducing downtime. In the US, the Company will focus on converting the substantial interest and test samples that have been generated into commercial orders. We are continually encouraged by the market response to the technology and believe there is now a sound foundation for progress."

The Company will announce its interim results oTuesday 17 June 2008.

- Ends -

For further information:

Hardide plc

Robert Goddard, Executive Chairman

Jackie Robinson, Head of Communications

Tel: +44 (0) 1869 353 830

jrobinson@hardide.com

www.hardide.com

  

Seymour Pierce Limited

Nicola Marrin, Corporate Finance 

Tel: +44 (0) 20 7107 8000

nicolamarrin@seymourpierce.com

 

Media enquiries:

Abchurch

Henry Harrison-Topham / George Parker

Tel: +44 (0) 20 7398 7719

george.parker@abchurch-group.com

www.abchurch-group.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSEFEDSASEIM
Date   Source Headline
7th Oct 20219:05 amRNSSecond Price Monitoring Extn
7th Oct 20219:00 amRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSYear End Trading Update
9th Sep 20212:05 pmRNSSecond Price Monitoring Extn
9th Sep 20212:00 pmRNSPrice Monitoring Extension
9th Sep 20217:00 amRNSContract Award
14th Jul 20218:17 amRNSHolding(s) in Company
6th Jul 20217:00 amRNSNew Facility Receives Airbus Approval
5th Jul 20213:46 pmRNSHolding(s) in Company
7th Jun 202111:00 amRNSHolding(s) in Company
19th May 20215:37 pmRNSHolding(s) in Company
18th May 20217:00 amRNSInterim Results
28th Apr 20213:16 pmRNSHolding(s) in Company
19th Mar 20213:19 pmRNSHolding(s) in Company
15th Mar 202112:06 pmRNSResult of AGM
15th Mar 20217:00 amRNSAGM Statement
25th Feb 202110:22 amRNSIssue of Options
19th Feb 20215:01 pmRNSHolding(s) in Company
19th Feb 20217:00 amRNSNotice of AGM
5th Feb 20217:00 amRNSHolding(s) in Company
1st Feb 202110:50 amRNSResult of Fundraising
1st Feb 20217:00 amRNSProposed equity fundraising and CBILS loan
7th Dec 20207:00 amRNSPreliminary results for year ended 30 Sept 2020
23rd Sep 20207:00 amRNSPre-close Trading Update
3rd Aug 20205:24 pmRNSDirector Dealing - Correction
3rd Aug 202012:17 pmRNSDirector Dealing
23rd Jul 20207:00 amRNSResignation of Non-Executive Director
16th Jul 20207:00 amRNSTrading Update
25th Jun 20202:30 pmRNSExercise of Options
23rd Jun 20202:14 pmRNSHolding(s) in Company
17th Jun 20203:43 pmRNSChange of Registered Office
20th May 20204:37 pmRNSIssue of Options
19th May 20207:00 amRNSInterim Results
21st Apr 20207:00 amRNSQueen’s Award for Enterprise
14th Apr 20205:00 pmRNSExercise of Options
31st Mar 20207:00 amRNSTRADING UPDATE AND THE IMPACT OF COVID-19
17th Feb 202012:47 pmRNSResult of AGM
17th Feb 20207:00 amRNSAGM Statement
10th Feb 20207:00 amRNSPresenting at The Growth & Innovation Forum
27th Jan 20202:43 pmRNSHolding(s) in Company
27th Jan 20207:00 amRNSAppointment of Finance Director
21st Jan 20208:15 amRNSDirector/PDMR Shareholding
21st Jan 20207:00 amRNSPlacing to raise £2.5 million
16th Dec 20195:22 pmRNSGrant of Options
9th Dec 20197:00 amRNSPreliminary Results
13th Nov 20197:00 amRNSHardide approved for F-35 Joint Strike Fighter
11th Nov 20197:00 amRNSPatent Award
15th Oct 20198:23 amRNSHolding(s) in Company
26th Sep 20197:00 amRNSTrading Update
23rd Aug 20197:00 amRNSAppointment of Joint Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.